Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Thomas J. George, MD, on the evolving treatment landscape of locally advanced rectal cancer

Dr. George, Director, GI Oncology Program, University of Florida, speculates on the evolving treatment landscape of locally advanced rectal cancer and whether potential improvements in outcomes are on the horizon for this disease

Tags: ASCO GI Conference CoverageColorectal

Published: 16 January 2021

Recent Videos

video

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, considers the progress being made at the community ...

video

Johnetta Blakely, MD, offers an example of how HEOR has impacted cancer care at Tennessee Oncology

Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, offers a case example of how real-world evidence ...

video

Johnetta Blakely, MD, elaborates on how HEOR may be used in conjunction with real-world evidence

Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, elaborates on how health economics outcomes research (HEOR) ...

video

Johnetta Blakely, MD, considers how HEOR data influences payer decisions

Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, considers how health economics and outcomes research (HEOR) ...

video

Johnetta Blakely, MD, explains the role of HEOR as it contributes to value-based care

Dr. Blakely, Executive Director of Health Economics Outcomes Research (HEOR), Tennessee Oncology, explains the role of health economics outcomes research ...

video

Jonathan E. Levitt, Esq., considers how PBM behaviors are changing as a result of the pandemic

Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, considers how pharmacy benefit manager (PBM) behaviors are changing as a result ...

video

Jonathan E. Levitt, Esq., offers opinion on PBM consolidation & the changing dynamics of cancer care

Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, offers opinion on PBM consolidation and the changing dynamics of cancer care

video

Jonathan E. Levitt, Esq., explains how copay aggregators differ across PBMs

Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, explains how copay aggregators differ across PBMs

video

Jonathan E. Levitt, Esq., on the experience of hem/onc groups unable to enter into a PBM network

Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, considers the experience of hematology/oncology groups who are unable to enter into a ...

video

Jonathan E. Levitt, Esq., explains how DIR fees impact practice costs and efficiencies

Jonathan E. Levitt, Esq., Co-Founding Partner, Frier Levitt, explains how DIR fees impact practice costs and efficiencies

Related Videos

video-image

Johnetta Blakely, MD, explains the role of HEOR as it contributes to value-based care

video-image

Johnetta Blakely, MD, considers how HEOR data influences payer decisions

video-image

Johnetta Blakely, MD, elaborates on how HEOR may be used in conjunction with real-world evidence

video-image

Johnetta Blakely, MD, offers an example of how HEOR has impacted cancer care at Tennessee Oncology

video-image

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

video-image

Jonathan E. Levitt, Esq., explains how DIR fees impact practice costs and efficiencies

video-image

Jonathan E. Levitt, Esq., on the experience of hem/onc groups unable to enter into a PBM network

video-image

Jonathan E. Levitt, Esq., explains how copay aggregators differ across PBMs

video-image

Jonathan E. Levitt, Esq., offers opinion on PBM consolidation & the changing dynamics of cancer care

video-image

Jonathan E. Levitt, Esq., considers how PBM behaviors are changing as a result of the pandemic

video-image

Sara Riordan, MS, CGC, on how genetic signature & biomarker tests are used in cancer management

video-image

Sara Riordan, MS, CGC, regarding the significance of biomarker testing in early-stage cancer

video-image

Sara Riordan, MS, CGC, on the role of genetic counselors as part of a multidisciplinary cancer team

video-image

Jonathan E. Levitt, Esq., discusses the state of payer mandates for white / brown bagging

video-image

Sara Riordan, MS, CGC, elaborates on the unmet needs in biomarker testing

video-image

Lalan S. Wilfong, MD, speculates on the future of oncology medical homes

video-image

Lalan S. Wilfong, MD, offers opinion on the key success factors for new payment reform models

video-image

Lalan S. Wilfong, MD, considers the impact of the Oncology Care First model

video-image

Lalan S. Wilfong, MD, regarding the impact of geographic location on the delivery of cancer care

video-image

Lalan S. Wilfong, MD, discusses key takeaways from the 2021 Virtual Community Oncology Conference